ACG Wealth’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,168
Closed -$72K 541
2022
Q2
$72K Buy
+1,168
New +$72.3K 0.01% 381
2018
Q1
Sell
-2,929
Closed -$210K 324
2017
Q4
$210K Sell
2,929
-33
-1% -$2.51K 0.03% 302
2017
Q3
$240K Sell
2,962
-5,404
-65% -$413K 0.04% 233
2017
Q2
$592K Buy
8,366
+1,056
+14% +$70.3K 0.1% 174
2017
Q1
$496K Buy
7,310
+4,239
+138% +$298K 0.09% 169
2016
Q4
$220K Sell
3,071
-1,588
-34% -$118K 0.05% 207
2016
Q3
$369K Sell
4,659
-28,953
-86% -$2.35M 0.08% 175
2016
Q2
$2.8M Buy
33,612
+991
+3% +$87.9K 0.62% 44
2016
Q1
$3M Sell
32,621
-13,752
-30% -$1.24M 0.68% 37
2015
Q4
$4.69M Buy
46,373
+22,156
+91% +$2.31M 1.05% 20
2015
Q3
$2.38M Buy
24,217
+2,576
+12% +$286K 0.64% 47
2015
Q2
$2.53M Sell
21,641
-215
-1% -$23.5K 0.63% 45
2015
Q1
$2.15M Buy
21,856
+2,312
+12% +$235K 0.57% 56
2014
Q4
$1.84M Sell
19,544
-7,281
-27% -$753K 0.5% 62
2014
Q3
$2.86M Sell
26,825
-25,104
-48% -$2.46M 0.81% 27
2014
Q2
$4.3M Buy
51,929
+26,699
+106% +$2.08M 0.81% 47
2014
Q1
$1.79M Sell
25,230
-15,196
-38% -$1.19M 0.53% 57
2013
Q4
$3.04M Sell
40,426
-999
-2% -$69.6K 0.78% 44
2013
Q3
$2.6M Sell
41,425
-7,025
-14% -$420K 1.08% 23
2013
Q2
$2.48M Buy
+48,450
New +$2.53M 0.97% 27

Other funds holding GILD

ACG Wealth's GILD Position: Q3 2022 in Review

ACG Wealth sold out of Gilead Sciences (GILD) in Q3 2022, closing a stake of 1,168 shares — an estimated $72K sold.

ACG Wealth first reported a position in GILD in Q2 2013 and held it in 20 quarters. The position peaked at $4.69M in Q4 2015. 1,602 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

  • ACG Wealth reported no remaining Gilead Sciences position as of Q3 2022 after selling out during the quarter.
  • ACG Wealth sold 1,168 Gilead Sciences shares in Q3 2022, an estimated $72K.
  • ACG Wealth first reported a position in Gilead Sciences in Q2 2013 and held it in 20 quarters.
  • ACG Wealth's Gilead Sciences position peaked at $4.69M in Q4 2015.
  • 1,602 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.